Drug Profile
Research programme: estrogen down-regulated gene 1-targeting compounds - Predix
Latest Information Update: 21 Aug 2007
Price :
$50
*
At a glance
- Originator Predix Pharmaceuticals
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 27 Mar 2006 No development reported - Preclinical for Cancer in USA (unspecified route)